Skip Nav Destination
Issues
15 July 2006
-
Cover Image
Cover Image
Oxaliplatin-resistant colorectal cancer cells exhibit morphologic and molecular changes consistent with epithelial-to-mesenchymal transition. Immunofluorescent staining for E-cadherin (red, right panels) and β-catenin (green, left panels) on HT29 parental (upper panels) and oxaliplatin-resistant (lower panels) cells demonstrated changes in localization of E-cadherin and β-catenin from their usual cell membrane-associated site to the cytoplasm and nucleus, respectively. For further details, please see Yang et al. on page 4147. in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Editorial
The Biology Behind
CCR Drug Updates
Molecular Pathways
Review
Human Cancer Biology
Unexpected Abundance of HLA Class II Presented Peptides in Primary Renal Cell Carcinomas
Jörn Dengjel; Maria-Dorothea Nastke; Cécile Gouttefangeas; Gitsios Gitsioudis; Oliver Schoor; Florian Altenberend; Margret Müller; Björn Krämer; Anna Missiou; Martina Sauter; Jörg Hennenlotter; Dorothee Wernet; Arnulf Stenzl; Hans-Georg Rammensee; Karin Klingel; Stefan Stevanović
Isolation of Human Prostatic Epithelial Plasma Membranes for Proteomics Using Mirror Image Tissue Banking of Radical Prostatectomy Specimens
Kanishka Sircar; Louis Gaboury; Lydia Ouadi; Melanie Mecteau; Eleonora Scarlata; Fred Saad; Armen Aprikian; Simon Tanguay; Steven Lapointe; Christian Lussier; Tina Miletti; Joel Lanoix
Imaging, Diagnosis, Prognosis
Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival
Daniel F. Hayes; Massimo Cristofanilli; G. Thomas Budd; Matthew J. Ellis; Alison Stopeck; M. Craig Miller; Jeri Matera; W. Jeffrey Allard; Gerald V. Doyle; Leon W.W.M. Terstappen
High Fluorodeoxyglucose Uptake on Positron Emission Tomography in Patients with Advanced Non–Small Cell Lung Cancer on Platinum-Based Combination Chemotherapy
Kyung-Hun Lee; Se-Hoon Lee; Dong-Wan Kim; Won Jun Kang; June-Key Chung; Seock-Ah Im; Tae-You Kim; Young Whan Kim; Yung-Jue Bang; Dae Seog Heo
Inverse Effects of Mucin on Survival of Matched Hereditary Nonpolyposis Colorectal Cancer and Sporadic Colorectal Cancer Patients
Jeng-Fu You; Ling-Ling Hsieh; Chung Rong Changchien; Jinn-Shiun Chen; Jim-Ray Chen; Jy-Ming Chiang; Chien Yuh Yeh; Pao-Shiu Hsieh; Chung-Wei Fan; Chun-Ting Liu; Reiping Tang
Cancer Therapy: Clinical
Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer
Michael J. Robertson; James W. Mier; Theodore Logan; Michael Atkins; Henry Koon; Kevin M. Koch; Steven Kathman; Lini N. Pandite; Coreen Oei; Lyndon C. Kirby; Roxanne C. Jewell; William N. Bell; Linda M. Thurmond; Jill Weisenbach; Suzanne Roberts; Mohammed M. Dar
A Phase I Clinical and Pharmacokinetic Study of Oral CI-1033 in Combination with Docetaxel in Patients with Advanced Solid Tumors
Linda L. Garland; Manuel Hidalgo; David S. Mendelson; David P. Ryan; Banu K. Arun; Jennifer L. Lovalvo; Irene A. Eiseman; Stephen C. Olson; Peter F. Lenehan; Joseph P. Eder
Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas
Eunice L. Kwak; Janusz Jankowski; Sarah P. Thayer; Gregory Y. Lauwers; Brian W. Brannigan; Patricia L. Harris; Ross A. Okimoto; Sara M. Haserlat; David R. Driscoll; David Ferry; Beth Muir; Jeff Settleman; Charles S. Fuchs; Matthew H. Kulke; David P. Ryan; Jeff W. Clark; Dennis C. Sgroi; Daniel A. Haber; Daphne W. Bell
Cancer Therapy: Preclinical
Systemic Anti-CD25 Monoclonal Antibody Administration Safely Enhances Immunity in Murine Glioma without Eliminating Regulatory T Cells
Peter E. Fecci; Alison E. Sweeney; Peter M. Grossi; Smita K. Nair; Christopher A. Learn; Duane A. Mitchell; Xiuyu Cui; Thomas J. Cummings; Darell D. Bigner; Eli Gilboa; John H. Sampson
Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase In vivo
Rongrong Ge; Vaishali Rajeev; Partha Ray; Edmund Lattime; Susan Rittling; Satya Medicherla; Andy Protter; Alison Murphy; Jit Chakravarty; Sundeep Dugar; George Schreiner; Nicola Barnard; Michael Reiss
Overcoming Drug-Resistant Cancer by a Newly Developed Copper Chelate through Host-Protective Cytokine-Mediated Apoptosis
Ananda Mookerjee; Jayati Mookerjee Basu; Pranabananda Dutta; Surajit Majumder; Sankar Bhattacharyya; Jaydip Biswas; Smarajit Pal; Pratima Mukherjee; Sanghamitra Raha; Rathindra N. Baral; Tania Das; Thomas Efferth; Gourisankar Sa; Shyamal Roy; Soumitra K. Choudhuri
Correction
Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
Summary Statement: Novel Agents in the Treatment of Lung Cancer: Advances in Epidermal Growth Factor Receptor-Targeted Agents
Thomas J. Lynch; Alex A. Adjei; Paul A. Bunn, Jr.; Tim G. Eisen; Jeffrey Engelman; Glenwood D. Goss; Daniel A. Haber; John V. Heymach; Pasi A. Jänne; Bruce E. Johnson; David H. Johnson; Rogerio C. Lilenbaum; Matthew Meyerson; Alan B. Sandler; Lecia V. Sequist; Jeffrey Settleman; Kwok-Kin Wong; Carol S. Hart
Epidermal Growth Factor Receptor Mutation Testing in the Care of Lung Cancer Patients
Lecia V. Sequist; Victoria A. Joshi; Pasi A. Jänne; Daphne W. Bell; Panos Fidias; Neal I. Lindeman; David N. Louis; Jeffrey C. Lee; Eugene J. Mark; Janina Longtine; Peter Verlander; Raju Kucherlapati; Matthew Meyerson; Daniel A. Haber; Bruce E. Johnson; Thomas J. Lynch
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.